BMO Capital maintains Outperform on Neurocrine Bio. (NASDAQ: NBIX) price target of $75.00.Analyst Ian Somaiya comments on the mixed data ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE